The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly ...

Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until ...

We came across a bullish thesis on Neogen Corporation on Cornerstone Value’s Substack. In this article, we will summarize the ...

Neogen Corporation NEOG has recently entered into a strategic licensing and supply agreement with Syngenta. Under the agreement, Neogen will have exclusive rights to market and sell Talon-G and Talon ...

The firm maintains its Market Perform rating and expects share appreciation to hinge on more durable improvements in the P&L over the coming quarters. Neogen affirmed its fiscal 2026 sales guidance of ...

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Neogen Corporation (NASDAQ:NEOG) stands against other top falling ...

Neogen Corporation NEOG reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of 10 cents, which topped the Zacks Consensus Estimate by 42.86%. However, the bottom line compares ...

Neogen Co. (NASDAQ:NEOG – Get Free Report)’s share price traded down 2.7% during mid-day trading on Tuesday after Piper Sandler lowered their price target on the stock from $6.40 to $5.00. Piper ...